Interestingly, DG013A, a first generation pseudopeptide containing a phosphinic group was a potent inhibitor of ERAP1 and ERAP2 activity and was demonstrated to enhance CD8+ T-cell responses against a murine colon carcinoma cell line [99]. Here, ERAP1 is linked to colon carcinoma.